Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What CAGR And Valuation Are Anticipated For The Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market?

In recent years, the market size for therapeutics related to attention deficit hyperactivity disorder (ADHD) has experienced substantial growth. It is projected to expand from $13.21 billion in 2024 to $13.97 billion in 2025, representing a compound annual growth rate (CAGR) of 5.7%. Factors such as growing diagnostic awareness and screening programs, an increasing number of ADHD cases, progress in treatment methods, improvements in healthcare infrastructure, and the broadening of health insurance coverage have contributed to the historical growth of this market.

The market size for therapeutics treating attention deficit hyperactivity disorder (adhd) is projected to witness significant growth in the upcoming years. It’s estimated to reach a value of “$17 billion by 2029, growing at a compound annual growth rate (CAGR) of 5.0%. This growth during the forecast period can be linked to factors such as advancements in genetic research and personalized medicine, a rise in awareness about mental health, worldwide and national mental health campaigns, the broadening of telehealth services, and the inclusion of behavioral therapies. Key trends expected in the forecast period encompass technological advancements in treatments, research and development efforts, the incorporation of digital therapeutics, precision medicine strategies, and innovative drug delivery systems.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14042&type=smp

Which Key Factors Are Fueling Growth In The Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market?

The growth of the Attention-Deficit Hyperactivity Disorder (ADHD) therapeutics market is being accelerated by a surge in the prevalence of ADHD. When we talk about the increasing prevalence of ADHD, we’re referring to the rising number of individuals being diagnosed with this particular neurodevelopmental disorder as time goes by. The therapeutic strategies utilized in ADHD target the multifarious aspects of the disorder, with the goal of enhancing symptom control, diminishing functional disability, improving quality of life, and promoting overall wellness for those suffering from ADHD. For example, the Guardian, a US news publisher, produced reports in January 2023 indicating that about 170,000 known patients had been given prescriptions for ADHD in 2022, marking a 20.4% rise compared to the 141,000 known patients identified during the same timeframe in 2021. Consequently, it’s clear that the swelling prevalence of ADHD is fueling the expansion of the ADHD therapeutics market.

Which Sub-Segments Are Driving Growth Within The Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market?

The attention deficit hyperactivity disorder (adhd) therapeutics market covered in this report is segmented –

1) By Drug Type: Stimulants, Non-Stimulants

2) By Psychotherapy: Behavior Therapy, Cognitive Behavioral Therapy, Interpersonal Psychotherapy, Family Therapy

3) By Age Group: Pediatric And Adolescent, Adult

4) By Distribution Channel: Hospital Pharmacies, Specialty Clinics, Retail Pharmacies, E-Commerce

Subsegments:

1) By Stimulants: Amphetamine-Based Stimulants, Methylphenidate-Based Stimulants

2) By Non-Stimulants: Atomoxetine, Guanfacine, Clonidine

What Future-Focused Trends Are Anticipated In The Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market?

Key players in the attention-deficit hyperactivity disorder (ADHD) therapeutics market are turning their focus towards the creation of digital innovations such as Endeavor over-the-counter (OTC) digital therapeutics for ADHD. This shift is driven by the rise in demand for digital solutions and remote healthcare. Digital therapeutics are primarily software-driven, evidence-based treatment methods developed to prevent, manage or treat health issues or diseases. They can function independently or as a supplement to traditional medical practices. For example, Akili, a digital health firm based in the US, launched an OTC variant of its digital therapeutic video game for adults suffering from ADHD in June 2023. Named EndeavorOTC, it aims to enhance attention span, time management, and organizational capabilities. This development came after the successful authorization by FDA of Akili’s prescription video game treatment, EndeavorRx, for children with ADHD. The OTC version offers a drug-free alternative for adults to manage their ADHD symptoms.

Which Players Are Shaping The Competitive Landscape Of The Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market?

Major companies operating in the attention deficit hyperactivity disorder (ADHD) therapeutics market are Pfizer Inc., Johnson And Johnson Services Inc., Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical’s, Eli Lilly and Company, Otsuka Pharmaceutical Co. Ltd., UCB S.A., Amneal Pharmaceuticals LLC, Lupin Ltd., Mallinckrodt Pharmaceuticals Inc., Hisamitsu Pharmaceutical Co. Inc., Purdue Pharma L.P., Arbor Pharmaceuticals LLC, Tris Pharma Inc., NEOS Therapeutic Inc., Concert Pharmaceuticals Inc., Vayarin AG, Rhodes Pharmaceuticals L.P., KemPharm Inc., Impax Laboratories Inc., Aevi Genomic Medicine, Adlon Therapeutics L.P., Ironshore Pharmaceuticals Inc., Highland Therapeutics Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/attention-deficit-hyperactivity-disorder-adhd-therapeutics-global-market-report

How Do Regional Dynamics Influence The Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Performance?

North America was the largest region in the attention deficit hyperactivity disorder (ADHD) therapeutic market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the attention deficit hyperactivity disorder (ADHD) therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=14042&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model